Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells.
In these studies, we determined whether there are receptors for the anaphylatoxin C5a (C5aR, CD88) on human mesangial cells (HMC). To prepare Abs to C5aR, we first synthesized an immunogenic peptide spanning residues 8-32 of the molecule, and this peptide was used to immunize rabbits. Anti-C5aR antiserum, but not preimmune serum, stained fixed and unfixed HMC in culture. By Western blotting anti-C5aR, Abs identified a 49.6-kDa protein in HMC. By reverse-transcription PCR, a cDNA product of 558 bp was amplified corresponding to the expected size of C5aR cDNA. A cDNA of the same size was amplified simultaneously from human PBL. Restriction mapping of the products amplified from HMC and from PBL gave restriction fragments of the same size. Incubation of HMC with increasing doses of C5a caused a progressive increase in the levels of the transcription factors activator protein-1 (AP-1) and cAMP response element binding protein (CREB), but C5a had no effect on the level of nuclear factor-kappaB (NF-kappaB). The effects of C5a on AP-1 were concentration and time dependent and peaked after 60 min. In contrast, the C5a metabolite C5adesArg had no significant effect on AP-1 levels. Preincubation of HMC with rabbit anti-C5aR antiserum inhibited partially the effect of C5a on AP-1. However, anti-C5aR Abs alone had no appreciable effects on AP-1. C5a caused a significant up-regulation of mRNA for the early response genes c-jun and c-fos on HMC. These results provide evidence for the presence of C5aR in adult HMC in culture and indicate that, after binding to C5aR, the anaphylatoxin C5a causes significant up-regulation of certain transcription factors and early response genes.
Wilmer
W A
WA
Department of Internal Medicine, The Ohio State University, Columbus 43210, USA.
Kaumaya
P T
PT
Ember
J A
JA
Cosio
F G
FG
D000328:Adult; D015703:Antigens, CD / Q000032:analysis* / Q000235:genetics; D002478:Cells, Cultured; D015936:Complement C5a / Q000378:metabolism* / Q000494:pharmacology; D017362:Cyclic AMP Response Element-Binding Protein / Q000276:immunology / Q000378:metabolism; D016762:Genes, fos / Q000187:drug effects / Q000276:immunology; D016758:Genes, jun / Q000187:drug effects / Q000276:immunology; D005920:Glomerular Mesangium / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D012333:RNA, Messenger / Q000032:analysis / Q000378:metabolism; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement / Q000032:analysis* / Q000235:genetics; D018808:Transcription Factor AP-1 / Q000276:immunology / Q000378:metabolism; D015854:Up-Regulation / Q000276:immunology
D015703:Antigens, CD; D017362:Cyclic AMP Response Element-Binding Protein; D012333:RNA, Messenger; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement; D018808:Transcription Factor AP-1; D015936:Complement C5a